tiprankstipranks
Intensity Therapeutics, Inc. (INTS)
:INTS
US Market

Intensity Therapeutics, Inc. (INTS) Financial Statements

Compare
29 Followers

Intensity Therapeutics, Inc. Financial Overview

Intensity Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-1.17; its P/E ratio is ―; Intensity Therapeutics, Inc. is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -147.00K$ -179.04K$ 0.00$ 0.00
Operating Income$ -16.59M$ -8.32M$ -7.63M$ -8.01M$ -6.22M
EBITDA$ -16.59M$ -10.09M$ -7.40M$ -7.88M$ -6.03M
Net Income$ -16.27M$ -10.54M$ -7.45M$ -7.89M$ -5.96M
Balance Sheet
Cash & Short-Term Investments$ 2.59M$ 14.78M$ 1.31M$ 4.54M$ 9.32M
Total Assets$ 4.78M$ 17.30M$ 1.76M$ 5.22M$ 10.15M
Total Debt$ 138.00K$ 158.00K$ 4.49M$ 2.34M$ 497.48K
Net Debt$ -2.45M$ -8.40M$ 3.18M$ -2.20M$ -8.82M
Total Liabilities$ 1.86M$ 4.13M$ 16.85M$ 13.90M$ 11.71M
Stockholders' Equity$ 2.92M$ 13.16M$ -15.10M$ -8.68M$ -1.56M
Cash Flow
Free Cash Flow$ -15.22M$ -7.21M$ -5.48M$ -6.83M$ -5.37M
Operating Cash Flow$ -15.22M$ -7.21M$ -5.48M$ -6.83M$ -5.37M
Investing Cash Flow$ 6.35M$ -6.02M$ 0.00$ 0.00$ 4.56M
Financing Cash Flow$ 2.90M$ 20.47M$ 2.25M$ 2.05M$ 6.29M
Currency in USD

Intensity Therapeutics, Inc. Earnings and Revenue History

Intensity Therapeutics, Inc. Debt to Assets

Intensity Therapeutics, Inc. Cash Flow

Intensity Therapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis